We are live on ! Find out more
NSPR icon

InspireMD

7 hedge funds and large institutions have $815K invested in InspireMD in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17,443% more capital inflows, than outflows

Capital inflows: $1.75M | Capital outflows: $10K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

74.15% more ownership

Funds ownership: 2.82% → 76.97% (+74%)

40% more funds holding

Funds holding: 5 → 7 (+2)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NSPR Hedge Fund Activity: Q4 2017 in Review

7 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2017, worth a combined $815K — up 869% from $84.1K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NSPR positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.37M. The largest seller was Goldman Sachs, exiting entirely with an estimated $6K sold.

  • 7 institutional investors held InspireMD (NSPR) as of Q4 2017, up from 5 in Q3 2017.
  • Funds reported $815K of InspireMD stock for Q4 2017, up 869% quarter-over-quarter.
  • 3 funds opened new InspireMD positions in Q4 2017 and 1 closed out, a net change of +2 holders.
  • The largest InspireMD buyer in Q4 2017 was Sabby Management, an estimated $1.37M added.
  • The largest InspireMD seller in Q4 2017 was Goldman Sachs, an estimated $6K sold.

Based on aggregated 13F filings for Q4 2017.